HAMID RASHIDI, Plaintiff and Appellant, v. FRANKLIN MOSER, Defendant and Appellant.
No. S214430
Supreme Court of California
Dec. 15, 2014.
718
Balaban & Speilberger, Daniel Balaban, Andrew J. Speilberger; Esner, Chang & Boyer, Stuart B. Esner and Holly N. Boyer for Plaintiff and Appellant.
Thorsnes Bartolotta McGuire and Benjamin I. Siminou for Michael J. Barger as Amicus Curiae on behalf of Plaintiff and Appellant.
Steven B. Stevens for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiff and Appellant.
Tucker Ellis, E. Todd Chayet, Rebecca A. Lefler, Lauren H. Bragin and Corena G. Larimer for California Medical Association, California Dental Association, California Hospital Association and American Medical Association as Amici Curiae on behalf of Defendant and Appellant.
Manatt, Phelps & Phillips and Harry W.R. Chamberlain II for Association of Southern California Defense Counsel as Amicus Curiae on behalf of Defendant and Appellant.
Fred J. Hiestand for The Civil Justice Association of California as Amicus Curiae on behalf of Defendant and Appellant.
OPINION
CORRIGAN, J.—In professional negligence actions against health care providers, recovery of noneconomic damages is capped at $250,000. (
Here we consider whether a jury‘s award of noneconomic damages, reduced by the court to $250,000 under MICRA, may be further diminished by setting off the amount of a pretrial settlement attributable to noneconomic losses, even when the defendant who went to trial failed to establish the comparative fault of the settling defendant. The Court of Appeal held that such a further reduction is required by the MICRA cap.
We disagree. It would be anomalous to allow a defendant to obtain a setoff against damages for which he is solely liable. Neither the text nor the history of
I. BACKGROUND
A. Trial Court Proceedings
According to the complaint, 26-year-old Hamid Rashidi went to the emergency room at Cedars-Sinai Medical Center (Cedars-Sinai) in April 2007 with a severe nosebleed. He was treated and discharged, but returned the next month with the same symptom. Dr. Franklin Moser examined him and recommended surgery. In an operation performed the same day, Moser ran a catheter through an artery in Rashidi‘s leg up into his nose. Tiny particles were injected through the catheter to irreversibly block certain blood vessels. The particles were manufactured by Biosphere Medical, Inc. (Biosphere Medical). When Rashidi awoke after surgery, he was permanently blind in one eye.
Rashidi sued Moser and Cedars-Sinai for medical malpractice and medical battery. He sued Biosphere Medical for product liability, failure to warn, negligence per se, breach of express and implied warranty, and misrepresentation. The theory of liability against Biosphere Medical was that its particles were able to travel through very small blood vessels and collateral veins, causing a significant risk they would migrate to places other than the intended sites. They did so here, causing Rashidi‘s blindness. Rashidi claimed Biosphere Medical had failed to disclose this risk, or the fact that the particles were irregular in size. Instead it marketed them as being uniform, allowing particular arteries to be accurately targeted.
Rashidi settled with Biosphere Medical for $2 million and with Cedars-Sinai for $350,000. The case went to trial against Moser alone. Moser presented no evidence of Cedars-Sinai‘s fault, and the court ruled that the evidence was insufficient to support instructions on Biosphere Medical‘s degree of fault. The jury found that Moser‘s negligence caused Rashidi‘s injury. It awarded $125,000 for future medical care, $331,250 for past noneconomic damages, and $993,750 for future noneconomic damages. The court reduced the noneconomic damages to $250,000, conforming to the MICRA cap.
Moser sought offsets against the judgment for the pretrial settlements with Cedars-Sinai and Biosphere Medical. The court rejected this claim, finding no basis for allocating the settlement sums between economic and noneconomic
B. The Court of Appeal Decision
The Court of Appeal held that offsets were required.
A widely accepted method for making such a postverdict allocation was provided in Espinoza v. Machonga (1992) 9 Cal.App.4th 268, 276-277 (Espinoza). The percentage of the jury‘s award attributable to economic damages is calculated and applied to the settlement, yielding the amount that the nonsettling defendant is entitled to offset. (Espinoza, at p. 277; see Jones v. John Crane, Inc. (2005) 132 Cal.App.4th 990, 1006; Ehret v. Congoleum Corp., supra, 73 Cal.App.4th at p. 1320; Poire v. C.L. Peck/Jones Brothers Construction Corp. (1995) 39 Cal.App.4th 1832, 1838-1839.) Following this formula, the Court of Appeal determined that the percentage of Rashidi‘s award attributable to economic damages was 8.62 percent ($125,000 in economic damages divided by the total award of $1,450,000). Applying that percentage to the $2 million settlement with Biosphere Medical, the court concluded that
The court performed a different calculation for the Cedars-Sinai settlement. Cedars-Sinai, like Moser and unlike Biosphere Medical, is a health care provider protected by MICRA. Therefore, the court first reduced the jury‘s award of noneconomic damages to $250,000 under
The court then considered the intersection of the MICRA cap on noneconomic damages with the rule of
Here, Moser failed to establish that any other defendant was at fault. Thus,
Rashidi relied on Hoch v. Allied-Signal, Inc. (1994) 24 Cal.App.4th 48 (Hoch). The Hoch plaintiffs sought only noneconomic
The Hoch court disagreed. It reasoned in part that comparing the total recovery with the jury‘s award was inappropriate, because “[s]ettlement dollars are not the same as damages. Settlement dollars represent a contractual estimate of the value of the settling tortfeasor‘s liability and may be more or less than the proportionate share of the plaintiff[‘]s damages. The settlement includes not only damages, but also the value of avoiding the risk, expense, and adverse public exposure that accompany going to trial. There is no conceptual inconsistency in allowing a plaintiff to recover more from a settlement or partial settlement than he could receive as damages.” (Hoch, supra, 24 Cal.App.4th at pp. 67-68, quoting Duncan v. Cessna Aircraft Co. (Tex. 1984) 665 S.W.2d 414, 431-432.)
The Court of Appeal here was not persuaded. Noting that neither Hoch nor Duncan involved a cap on damages like MICRA‘s, the court said, “MICRA does not distinguish between settlement dollars and judgments; it addresses a plaintiff‘s total recovery for noneconomic losses.” The court concluded that MICRA, as the more specific statute, must be read as an exception to
We granted Rashidi‘s petition for review, limiting the question to the propriety of the setoff against noneconomic damages granted by the Court of Appeal.
II. DISCUSSION
The relevant MICRA provisions are these:
“(a) In any action for injury against a health care provider based on professional negligence, the injured plaintiff shall be entitled to recover noneconomic losses to compensate for pain, suffering, inconvenience, physical impairment, disfigurement and other nonpecuniary damage.
“(b) In no action shall the amount of damages for noneconomic losses exceed two hundred fifty thousand dollars ($250,000).” (
§ 3333.2 .)
Rashidi argues that the plain terms of
Moser argues that subdivisions (a) and (b) of
Rashidi‘s reading of
“[T]he term ‘damages’ . . . , both in its legal and commonly understood or ‘ordinary and popular sense,’ is limited to ‘money ordered by a court’ . . . .” (County of San Diego v. Ace Property & Casualty Ins. Co. (2005) 37 Cal.4th 406, 417, quoting Certain Underwriters at Lloyd‘s of London v. Superior Court (2001) 24 Cal.4th 945,
It is clear that the Legislature knew how to include settlement dollars when it designed limits for purposes of medical malpractice litigation reform.
Neither the parties nor amici curiae direct us to anything in the legislative history of
Thus, the Legislature was primarily concerned with capricious jury awards when it established the MICRA cap. However, excluding settlement dollars from the cap does not leave settlements unaffected. The prospect of a fixed award of noneconomic damages not only increases plaintiffs’ motive to settle, as noted in Fein, but also restrains the size of settlements. Settlement negotiations are based on liability estimates that are necessarily affected by the cap. By placing an upper limit on the recovery of noneconomic damages at trial, the Legislature indirectly but effectively influenced the parties’ settlement calculations.
Allowing the proportionate liability rule of
Our reading of the statutes is confirmed by considering an alternate scenario, where it is clear the MICRA cap could not function effectively as a limit on recovery for noneconomic losses by way of settlement. Suppose the Cedars-Sinai and Biosphere Medical settlements in this case were interchanged, so that Cedars-Sinai settled for $2 million and Biosphere Medical for $350,000. In that circumstance, under either of the allocation formulas applied by the Court of Appeal, the portion of the Cedars-Sinai settlement attributable to noneconomic losses would far exceed the $250,000 cap imposed by
We conclude that the cap imposed by
III. DISPOSITION
The Court of Appeal‘s judgment is reversed insofar as it reduced the award of noneconomic damages below $250,000, and affirmed in all other respects.
Cantil-Sakauye, C. J., Baxter, J., Werdegar, J., Chin, J., Liu, J., and Detjen, J.,* concurred.
*Associate Justice of the Court of Appeal, Fifth Appellate District, assigned by the Chief Justice pursuant to article VI, section 6 of the California Constitution.
